The purpose of this study is to assess whether intensive case management interventions by a diabetes team, led by an endocrinologist and certified diabetes educator, can prevent \<31 day readmission in previously identified high risk patients with diabetes.The procedures of the study will focus on managing the patient's diabetes and diabetes education while in the hospital, decreasing the patient's risk for hypoglycemia and hyperglycemia in the hospital, and assist in the patient's diabetes management plan for a safe discharge.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1
A diabetes team , led by an endocrinologist and CDE, will manage the patients diabetes while in the hospital and will assist with the patient's discharge Diabetes endocrine consult team will manage the patient's diabetes daily while in the hospital Discharge diabetes medication reconciliation per research team Research team will provide 30 day supply of diabetes medication/supplies at discharge Research Team will provide 30 day supply of glucose test strips at discharge Discharge telecommunication from endocrinologist to primary care provider Patient-centered discharge diabetes education per research CDE Post-discharge 48-72 hours continuity check per phone by a diabetes research team member/CDE \--------------------------------------------------------------------------------
Barnes-Jewish Hospital
St Louis, Missouri, United States
Prevent <31 day readmission
Primary outcome measure is to assess whether an intensive case management intervention by a diabetes team, led by an endocrinologist and a certified diabetes educator (CDE) , can prevent a \<31 day readmission in previously identified high risk patients with diabetes compared to standard/usual care.
Time frame: The length of time between hospital discharge and readmission 31 days
improve overall glycemic management
To examine whether intensive case management intervention per endocrinologist and CDE during hospital stay prevents hypoglycemia \<70mg/dl, severe hypoglycemia \<40mg/dl, and improves overall glycemic management (100-180 mg/dl) compared to standard/usual care.
Time frame: Upon the participant's consent (within 24 hours of hospital admission) to hospital discharge- the average length of stay is five days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.